{
  "generated": "2025-10-27T01:50:36.320130+00:00",
  "policy_fingerprint": "0xbe3a798944b1c64b",
  "source_evidence": "entries/immune/quercetin-imm-querc-allergy/immune_health/v1/evidence.csv",
  "preferred_citation": "Kim G. TERVYX Protocol v1.0 (2025).",
  "studies": [
    {
      "study_id": "IMM-QUERC-ALLERGY-01",
      "year": 2013,
      "design": "randomized controlled trial",
      "journal": "immune_health-journal-01",
      "outcome": "allergic_rhinitis",
      "population": "Adults with allergic rhinitis concerns",
      "adverse_events": "None reported",
      "doi": "10.1234/imm-querc-allergy-01",
      "url": "https://doi.org/10.1234/imm-querc-allergy-01",
      "citation": "IMM-QUERC-ALLERGY-01 (2013); Journal: immune_health-journal-01; Design: randomized controlled trial; Population: Adults with allergic rhinitis concerns; Outcome: allergic_rhinitis; DOI: 10.1234/imm-querc-allergy-01; Adverse Events: None reported."
    },
    {
      "study_id": "IMM-QUERC-ALLERGY-02",
      "year": 2018,
      "design": "randomized controlled trial",
      "journal": "immune_health-journal-02",
      "outcome": "allergic_rhinitis",
      "population": "Adults with allergic rhinitis concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/imm-querc-allergy-02",
      "url": "https://doi.org/10.1234/imm-querc-allergy-02",
      "citation": "IMM-QUERC-ALLERGY-02 (2018); Journal: immune_health-journal-02; Design: randomized controlled trial; Population: Adults with allergic rhinitis concerns; Outcome: allergic_rhinitis; DOI: 10.1234/imm-querc-allergy-02; Adverse Events: Transient headache."
    },
    {
      "study_id": "IMM-QUERC-ALLERGY-03",
      "year": 2023,
      "design": "randomized controlled trial",
      "journal": "immune_health-journal-03",
      "outcome": "allergic_rhinitis",
      "population": "Adults with allergic rhinitis concerns",
      "adverse_events": "Transient headache",
      "doi": "10.1234/imm-querc-allergy-03",
      "url": "https://doi.org/10.1234/imm-querc-allergy-03",
      "citation": "IMM-QUERC-ALLERGY-03 (2023); Journal: immune_health-journal-03; Design: randomized controlled trial; Population: Adults with allergic rhinitis concerns; Outcome: allergic_rhinitis; DOI: 10.1234/imm-querc-allergy-03; Adverse Events: Transient headache."
    }
  ],
  "references": [
    {
      "type": "doi",
      "identifier": "10.1234/imm-querc-allergy-01",
      "study_ids": [
        "IMM-QUERC-ALLERGY-01"
      ],
      "primary_study_id": "IMM-QUERC-ALLERGY-01",
      "url": "https://doi.org/10.1234/imm-querc-allergy-01"
    },
    {
      "type": "doi",
      "identifier": "10.1234/imm-querc-allergy-02",
      "study_ids": [
        "IMM-QUERC-ALLERGY-02"
      ],
      "primary_study_id": "IMM-QUERC-ALLERGY-02",
      "url": "https://doi.org/10.1234/imm-querc-allergy-02"
    },
    {
      "type": "doi",
      "identifier": "10.1234/imm-querc-allergy-03",
      "study_ids": [
        "IMM-QUERC-ALLERGY-03"
      ],
      "primary_study_id": "IMM-QUERC-ALLERGY-03",
      "url": "https://doi.org/10.1234/imm-querc-allergy-03"
    }
  ],
  "manifest_hash": "sha256:f0bd24ab8e1266899c865db5fd58c7a4fac7a745d6c9659409142382b2c3b277"
}
